Skip to content

DENTSPLY SIRONA XRAY EBITDA margin

EBITDA margin at other companies

Align Technology logo
Align TechnologyALGN
19.8%+1.3pp
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
10%+5.5pp
Solventum logo
SolventumSOLV
31.5%+15.2pp
Henry Schein logo
Henry ScheinHSIC
7.2%-0.1pp
Globus Medical logo
Globus MedicalGMED
26.3%+5.6pp
Stryker logo
StrykerSYK
24.6%+4.7pp

Other financials

Income statement

See full
Revenue$880.0M+0.1%
Gross profit$427.0M-8.4%
Operating income-$35.0M-156%
Net income-$10.0M-150%
EPS (diluted)-$0.05-150%

Balance sheet

See full
Cash & equivalents$190.0M-52.3%
Total debt$2.3B-3.8%
Total equity$1.3B-34.4%
Total assets$5.2B-13.6%

Cash flow

See full
Operating cash flow$40.0M+471%
CapEx$52.0M+174%
Free cash flow-$12.0M0.0%

Valuation

See full
Market cap$2.11B-22.1%

Profitability

See full
Gross margin48.9%-2.6pp
Operating margin-14.1%-3.9pp
Net margin-17.1%-3.9pp
FCF margin2.8%-4.6pp

Returns & leverage

See full
Return on equity-37.7%+4.0pp
Debt / equity1.8×+0.6×
Current ratio1.5×+0.4×

Where this comes from

Calculated from DENTSPLY SIRONA’s reported figures.

Based on trailing twelve months.

The official record: DENTSPLY SIRONA’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about DENTSPLY SIRONA's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DENTSPLY SIRONA's EBITDA margin?
DENTSPLY SIRONA (XRAY) reported EBITDA margin of -4.6% in Q1 2026.
How has DENTSPLY SIRONA's EBITDA margin changed year-over-year?
DENTSPLY SIRONA's EBITDA margin increased by 67.1% year-over-year, from -13.9% to -4.6%.
What is the long-term trend for DENTSPLY SIRONA's EBITDA margin?
Over 4 years (2020 to 2025), DENTSPLY SIRONA's EBITDA margin has grown at a -33.8% compound annual growth rate (CAGR), from 9.9% to -1.9%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.